Bioavailability of aciclovir after oral administration of aciclovir and its prodrug valaciclovir to patients with leukopenia after chemotherapy
about
Pharmacokinetics of amino acid ester prodrugs of acyclovir after oral administration: interaction with the transporters on Caco-2 cells.Valacyclovir and acyclovir pharmacokinetics in immunocompromised children.The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: enhanced membrane permeability and enzymatic stabilityAdvances in the antiviral therapy of herpes virus infection in children.Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome (an American Ophthalmological Society thesis)Valacyclovir as Initial Treatment for Acute Retinal Necrosis: A Pharmacokinetic Modeling and Simulation Study.Planar microdevices for enhanced in vivo retention and oral bioavailability of poorly permeable drugs.Structure-based model profiles affinity constant of drugs with hPEPT1 for rapid virtual screening of hPEPT1's substrate.Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability.Development and characterization of a long-acting nanoformulated abacavir prodrugPharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir?An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children.Amino Acids in the Development of Prodrugs
P2860
Q33697974-DD98F33B-8150-483B-B9D7-9596FB84635CQ33776931-DD79C3E7-CB2B-4D52-9445-E81CEA02B538Q34570055-05DF9FCA-2BAE-4CEE-AA16-C709E800C118Q36688958-4C4904D3-A284-4123-9083-355F385FFBA5Q37404352-0F1F4DD5-74F1-470D-ABB0-C5CCE5FD03C5Q38867550-3DB44E58-8940-4C11-8AA1-D71C742050D1Q39213919-417FF84A-B174-4636-AA6B-070F278BA0C0Q39430625-761D200D-CF62-4A5D-A14E-90D35886E202Q39957747-DC0FB5FF-E2F3-4F89-B20B-39E1E4D3C7DCQ41280373-5355A468-7A02-4A6C-A061-E319F6C8AE45Q43584086-0E9AD8B8-74AA-4FEE-87C8-255437A28F95Q44157452-0CA30A84-7465-4136-9ACB-F411939AD43CQ58696356-194D8FF5-5C89-485D-9F3F-E188CA8E7A5A
P2860
Bioavailability of aciclovir after oral administration of aciclovir and its prodrug valaciclovir to patients with leukopenia after chemotherapy
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Bioavailability of aciclovir a ...... leukopenia after chemotherapy
@ast
Bioavailability of aciclovir a ...... leukopenia after chemotherapy
@en
type
label
Bioavailability of aciclovir a ...... leukopenia after chemotherapy
@ast
Bioavailability of aciclovir a ...... leukopenia after chemotherapy
@en
prefLabel
Bioavailability of aciclovir a ...... leukopenia after chemotherapy
@ast
Bioavailability of aciclovir a ...... leukopenia after chemotherapy
@en
P2093
P2860
P1476
Bioavailability of aciclovir a ...... leukopenia after chemotherapy
@en
P2093
P2860
P304
P356
10.1128/AAC.44.1.207-209.2000
P407
P577
2000-01-01T00:00:00Z